Matrix Latest Drug Testing News | Matrix Diagnostics
How workplace drug testing helps to save money in the war on drugs
24 September 2024
Posted By Matrix Diagnostics
0 Comments
Recently, there has been a lot of focus on funding to combat drug misuse and drug trafficking. At the end of 2021, the UK government announced a 10-year plan to actively tackle drug supply chains while capping the demand for drugs through treatment programmes. Allocated funding and initiatives A total of £3bn was earmarked for
Government bans xylazine and other substances to curb drug deaths
18 September 2024
Posted By Matrix Diagnostics
0 Comments
The UK Government has initiated steps to ban xylazine and 21 other drugs. After an investigation, the Advisory Council on the Misuse of Drugs (ACMD) recommended this ban as part of the continued battle against drug trafficking and alarmingly high drug deaths. Xylazine is a veterinary sedative and drug dealers often combine it with opioids
Matrix Diagnostics Achieves UKAS Accreditation for Oral Fluid Toxicology Analysis
2 September 2024
Posted By Oliwia Zakrzewska
0 Comments
We are pleased to announce that on 22nd August 2024, Matrix Diagnostics was awarded UKAS accreditation for analysis of oral fluid toxicology samples using a solid phase extraction method. This is a significant development for the Laboratory Team and is the culmination of a project to improve our technical methods for oral fluid analysis. The
Drug and alcohol screening market grows as use increases
28 August 2024
Posted By Matrix Diagnostics
0 Comments
Recent financial reports showed that the global drug and alcohol screening market currently carries a value of more than £7bn. Experts believe that this niche will maintain a compound annual growth rate (CAGR) of 16.6% and achieve a value of over £15.2bn by 2029. At its core, this market consists of companies that specialise in
